Liquidia Shares Tank On Patent Court Loss, Rivals May Just Be Getting Started (NASDAQ:LQDA)
· seekingalpha.com
Liquidia shares plunged over 60% following a major patent setback related to its flagship drug Yutrepia. Click here to read this latest analysis of LQDA stock.
If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and ...